Arkolith/Insider Trading/CRXT/Form 4

Olifant Fund, Ltd.

10% OwnerClarus Therapeutics Holdings, Inc. (CRXT) · full profile →Form 4 · filed Sep 21, 2021
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.2M
Net Open-Market Flow
-$1.2M
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 17, 2021Sell(S)127K$9.20$1.2M2.1M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-21-117993) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML